A Study of Atezolizumab in Combination With Carboplatin Plus Etoposide to Investigate Safety and Efficacy in Patients With Untreated Extensive-Stage Small Cell Lung Cancer
Clinical trial NCT04028050 · COMPLETED
Trial details
- NCT number
- NCT04028050
- Sponsor
- Hoffmann-La Roche
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2019-08-12
- Primary completion
- 2023-07-13
- Enrollment
- 155
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.